Factors associated with emotional distress in newly-diagnosed prostate cancer identified
the ONA take:
According to a new study published in the journal Psycho-Oncology, researchers from the University at Buffalo Department of Community Health and Health Behavior in Buffalo, New York, have identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
For the study, researchers sought to identify factors associated with significant emotional distress in men with newly diagnosed prostate cancer so that may identify acceptable intervention strategies to manage that distress.
Researchers identified 1,425 men with newly diagnosed clinically localized prostate cancer who had not received treatment for their disease yet.
Participants used the Distress Thermometer to report how much distress they were experiencing and identify what problems they experienced in the past week. Results showed that low self-efficacy for decision-making, low confidence in cancer control, masculine identity threat, low optimism, and low resilience were associated with higher emotional distress.
The findings suggest that improving communication about prostate cancer prognosis, providing decision-making support, and referring to brief cognitive behavioral interventions may be useful approaches at mitigating significant emotional distress for those with newly diagnosed prostate cancer.
Researchers identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|